GRN and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: In both datasets, MVP, GRN, and ERP29 showed significantly higher expression levels, while RNF128, NFYB, and KPNA3 had significantly lower expression levels in dysferlinopathy than normal controls (Figures 5A,B).